Shanxi Cancer Hospital: Clinical Trials & Research Profile

Hospital / Clinical Site in Taiyuan, China · Primary Specialty: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeClinical Trial Research Site
Institutional Sector & LocationHospital / Clinical Site (Taiyuan, China)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies88 active (41 recruiting now)
Total Tracked Studies (2018 to 2026)106
Completed vs Early-Stopped Studies1 completed / 3 stopped (2.8% stop rate)
Median Closed Enrollment85 participants
Median Completed Study Duration401 calendar days
Physical Hospital Site Disclosure100.0% named hospital campus

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk